Global Dexamethasone Sodium Phosphate Injection Market Research Report 2023

Publication ID:

PB503237608

Publication Date:

March 13, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Used for allergic and autoimmune inflammatory diseases. Mostly used for connective tissue disease, active rheumatism, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, severe dermatitis, ulcerative colitis, acute leukemia, etc.
Highlights
The global Dexamethasone Sodium Phosphate Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Dexamethasone Sodium Phosphate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Dexamethasone Sodium Phosphate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Dexamethasone Sodium Phosphate Injection include AuroMedics, Fresenius Kabi, Hikma, Mylan, Somerset Therapeutics, American Regent, Shanghai General Pharmaceutical, Hunan Hansen Pharm and Chengdu Brilliant Pharmaceutical, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dexamethasone Sodium Phosphate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexamethasone Sodium Phosphate Injection.
The Dexamethasone Sodium Phosphate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dexamethasone Sodium Phosphate Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dexamethasone Sodium Phosphate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AuroMedics
Fresenius Kabi
Hikma
Mylan
Somerset Therapeutics
American Regent
Shanghai General Pharmaceutical
Hunan Hansen Pharm
Chengdu Brilliant Pharmaceutical
Cisen Pharmaceutical
CSPC Group
Jiangsu Wuzhong Pharm
Guangzhou Baiyunshan Tianxin Pharmaceutical
Segment by Type
4 mg/ml
10 mg/ml
Segment by Application
Hospital
Clinics
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dexamethasone Sodium Phosphate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dexamethasone Sodium Phosphate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Dexamethasone Sodium Phosphate Injection Market Overview
1.1 Product Overview and Scope of Dexamethasone Sodium Phosphate Injection
1.2 Dexamethasone Sodium Phosphate Injection Segment by Type
1.2.1 Global Dexamethasone Sodium Phosphate Injection Market Value Comparison by Type (2023-2029)
1.2.2 4 mg/ml
1.2.3 10 mg/ml
1.3 Dexamethasone Sodium Phosphate Injection Segment by Application
1.3.1 Global Dexamethasone Sodium Phosphate Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Global Dexamethasone Sodium Phosphate Injection Market Size Estimates and Forecasts
1.4.1 Global Dexamethasone Sodium Phosphate Injection Revenue 2018-2029
1.4.2 Global Dexamethasone Sodium Phosphate Injection Sales 2018-2029
1.4.3 Global Dexamethasone Sodium Phosphate Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dexamethasone Sodium Phosphate Injection Market Competition by Manufacturers
2.1 Global Dexamethasone Sodium Phosphate Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dexamethasone Sodium Phosphate Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dexamethasone Sodium Phosphate Injection Average Price by Manufacturers (2018-2023)
2.4 Global Dexamethasone Sodium Phosphate Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dexamethasone Sodium Phosphate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dexamethasone Sodium Phosphate Injection, Product Type & Application
2.7 Dexamethasone Sodium Phosphate Injection Market Competitive Situation and Trends
2.7.1 Dexamethasone Sodium Phosphate Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dexamethasone Sodium Phosphate Injection Players Market Share by Revenue
2.7.3 Global Dexamethasone Sodium Phosphate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dexamethasone Sodium Phosphate Injection Retrospective Market Scenario by Region
3.1 Global Dexamethasone Sodium Phosphate Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dexamethasone Sodium Phosphate Injection Global Dexamethasone Sodium Phosphate Injection Sales by Region: 2018-2029
3.2.1 Global Dexamethasone Sodium Phosphate Injection Sales by Region: 2018-2023
3.2.2 Global Dexamethasone Sodium Phosphate Injection Sales by Region: 2024-2029
3.3 Global Dexamethasone Sodium Phosphate Injection Global Dexamethasone Sodium Phosphate Injection Revenue by Region: 2018-2029
3.3.1 Global Dexamethasone Sodium Phosphate Injection Revenue by Region: 2018-2023
3.3.2 Global Dexamethasone Sodium Phosphate Injection Revenue by Region: 2024-2029
3.4 North America Dexamethasone Sodium Phosphate Injection Market Facts & Figures by Country
3.4.1 North America Dexamethasone Sodium Phosphate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dexamethasone Sodium Phosphate Injection Sales by Country (2018-2029)
3.4.3 North America Dexamethasone Sodium Phosphate Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dexamethasone Sodium Phosphate Injection Market Facts & Figures by Country
3.5.1 Europe Dexamethasone Sodium Phosphate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dexamethasone Sodium Phosphate Injection Sales by Country (2018-2029)
3.5.3 Europe Dexamethasone Sodium Phosphate Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dexamethasone Sodium Phosphate Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Dexamethasone Sodium Phosphate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dexamethasone Sodium Phosphate Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Dexamethasone Sodium Phosphate Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dexamethasone Sodium Phosphate Injection Market Facts & Figures by Country
3.7.1 Latin America Dexamethasone Sodium Phosphate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dexamethasone Sodium Phosphate Injection Sales by Country (2018-2029)
3.7.3 Latin America Dexamethasone Sodium Phosphate Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dexamethasone Sodium Phosphate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Dexamethasone Sodium Phosphate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dexamethasone Sodium Phosphate Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dexamethasone Sodium Phosphate Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dexamethasone Sodium Phosphate Injection Sales by Type (2018-2029)
4.1.1 Global Dexamethasone Sodium Phosphate Injection Sales by Type (2018-2023)
4.1.2 Global Dexamethasone Sodium Phosphate Injection Sales by Type (2024-2029)
4.1.3 Global Dexamethasone Sodium Phosphate Injection Sales Market Share by Type (2018-2029)
4.2 Global Dexamethasone Sodium Phosphate Injection Revenue by Type (2018-2029)
4.2.1 Global Dexamethasone Sodium Phosphate Injection Revenue by Type (2018-2023)
4.2.2 Global Dexamethasone Sodium Phosphate Injection Revenue by Type (2024-2029)
4.2.3 Global Dexamethasone Sodium Phosphate Injection Revenue Market Share by Type (2018-2029)
4.3 Global Dexamethasone Sodium Phosphate Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dexamethasone Sodium Phosphate Injection Sales by Application (2018-2029)
5.1.1 Global Dexamethasone Sodium Phosphate Injection Sales by Application (2018-2023)
5.1.2 Global Dexamethasone Sodium Phosphate Injection Sales by Application (2024-2029)
5.1.3 Global Dexamethasone Sodium Phosphate Injection Sales Market Share by Application (2018-2029)
5.2 Global Dexamethasone Sodium Phosphate Injection Revenue by Application (2018-2029)
5.2.1 Global Dexamethasone Sodium Phosphate Injection Revenue by Application (2018-2023)
5.2.2 Global Dexamethasone Sodium Phosphate Injection Revenue by Application (2024-2029)
5.2.3 Global Dexamethasone Sodium Phosphate Injection Revenue Market Share by Application (2018-2029)
5.3 Global Dexamethasone Sodium Phosphate Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AuroMedics
6.1.1 AuroMedics Corporation Information
6.1.2 AuroMedics Description and Business Overview
6.1.3 AuroMedics Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AuroMedics Dexamethasone Sodium Phosphate Injection Product Portfolio
6.1.5 AuroMedics Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Fresenius Kabi Dexamethasone Sodium Phosphate Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Hikma
6.3.1 Hikma Corporation Information
6.3.2 Hikma Description and Business Overview
6.3.3 Hikma Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hikma Dexamethasone Sodium Phosphate Injection Product Portfolio
6.3.5 Hikma Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Dexamethasone Sodium Phosphate Injection Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Somerset Therapeutics
6.5.1 Somerset Therapeutics Corporation Information
6.5.2 Somerset Therapeutics Description and Business Overview
6.5.3 Somerset Therapeutics Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Somerset Therapeutics Dexamethasone Sodium Phosphate Injection Product Portfolio
6.5.5 Somerset Therapeutics Recent Developments/Updates
6.6 American Regent
6.6.1 American Regent Corporation Information
6.6.2 American Regent Description and Business Overview
6.6.3 American Regent Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 American Regent Dexamethasone Sodium Phosphate Injection Product Portfolio
6.6.5 American Regent Recent Developments/Updates
6.7 Shanghai General Pharmaceutical
6.6.1 Shanghai General Pharmaceutical Corporation Information
6.6.2 Shanghai General Pharmaceutical Description and Business Overview
6.6.3 Shanghai General Pharmaceutical Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai General Pharmaceutical Dexamethasone Sodium Phosphate Injection Product Portfolio
6.7.5 Shanghai General Pharmaceutical Recent Developments/Updates
6.8 Hunan Hansen Pharm
6.8.1 Hunan Hansen Pharm Corporation Information
6.8.2 Hunan Hansen Pharm Description and Business Overview
6.8.3 Hunan Hansen Pharm Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hunan Hansen Pharm Dexamethasone Sodium Phosphate Injection Product Portfolio
6.8.5 Hunan Hansen Pharm Recent Developments/Updates
6.9 Chengdu Brilliant Pharmaceutical
6.9.1 Chengdu Brilliant Pharmaceutical Corporation Information
6.9.2 Chengdu Brilliant Pharmaceutical Description and Business Overview
6.9.3 Chengdu Brilliant Pharmaceutical Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Chengdu Brilliant Pharmaceutical Dexamethasone Sodium Phosphate Injection Product Portfolio
6.9.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
6.10 Cisen Pharmaceutical
6.10.1 Cisen Pharmaceutical Corporation Information
6.10.2 Cisen Pharmaceutical Description and Business Overview
6.10.3 Cisen Pharmaceutical Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cisen Pharmaceutical Dexamethasone Sodium Phosphate Injection Product Portfolio
6.10.5 Cisen Pharmaceutical Recent Developments/Updates
6.11 CSPC Group
6.11.1 CSPC Group Corporation Information
6.11.2 CSPC Group Dexamethasone Sodium Phosphate Injection Description and Business Overview
6.11.3 CSPC Group Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CSPC Group Dexamethasone Sodium Phosphate Injection Product Portfolio
6.11.5 CSPC Group Recent Developments/Updates
6.12 Jiangsu Wuzhong Pharm
6.12.1 Jiangsu Wuzhong Pharm Corporation Information
6.12.2 Jiangsu Wuzhong Pharm Dexamethasone Sodium Phosphate Injection Description and Business Overview
6.12.3 Jiangsu Wuzhong Pharm Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Jiangsu Wuzhong Pharm Dexamethasone Sodium Phosphate Injection Product Portfolio
6.12.5 Jiangsu Wuzhong Pharm Recent Developments/Updates
6.13 Guangzhou Baiyunshan Tianxin Pharmaceutical
6.13.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
6.13.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Dexamethasone Sodium Phosphate Injection Description and Business Overview
6.13.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Dexamethasone Sodium Phosphate Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Dexamethasone Sodium Phosphate Injection Product Portfolio
6.13.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dexamethasone Sodium Phosphate Injection Industry Chain Analysis
7.2 Dexamethasone Sodium Phosphate Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dexamethasone Sodium Phosphate Injection Production Mode & Process
7.4 Dexamethasone Sodium Phosphate Injection Sales and Marketing
7.4.1 Dexamethasone Sodium Phosphate Injection Sales Channels
7.4.2 Dexamethasone Sodium Phosphate Injection Distributors
7.5 Dexamethasone Sodium Phosphate Injection Customers
8 Dexamethasone Sodium Phosphate Injection Market Dynamics
8.1 Dexamethasone Sodium Phosphate Injection Industry Trends
8.2 Dexamethasone Sodium Phosphate Injection Market Drivers
8.3 Dexamethasone Sodium Phosphate Injection Market Challenges
8.4 Dexamethasone Sodium Phosphate Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AuroMedics
Fresenius Kabi
Hikma
Mylan
Somerset Therapeutics
American Regent
Shanghai General Pharmaceutical
Hunan Hansen Pharm
Chengdu Brilliant Pharmaceutical
Cisen Pharmaceutical
CSPC Group
Jiangsu Wuzhong Pharm
Guangzhou Baiyunshan Tianxin Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂